Interchange Capital Partners LLC cut its holdings in shares of SPDR S&P Biotech ETF (NYSEARCA:XBI – Free Report) by 77.5% during the second quarter, HoldingsChannel.com reports. The firm owned 601 shares of the exchange traded fund’s stock after selling 2,071 shares during the quarter. Interchange Capital Partners LLC’s holdings in SPDR S&P Biotech ETF were worth $50,000 at the end of the most recent quarter.
A number of other large investors also recently added to or reduced their stakes in XBI. Dynamic Advisor Solutions LLC acquired a new position in SPDR S&P Biotech ETF during the 1st quarter valued at about $825,000. Sowell Financial Services LLC acquired a new stake in shares of SPDR S&P Biotech ETF in the 1st quarter valued at approximately $686,000. Insigneo Advisory Services LLC bought a new position in SPDR S&P Biotech ETF during the 1st quarter worth approximately $217,000. Cornerstone Wealth Management LLC boosted its stake in SPDR S&P Biotech ETF by 11.8% during the 1st quarter. Cornerstone Wealth Management LLC now owns 6,460 shares of the exchange traded fund’s stock worth $524,000 after acquiring an additional 684 shares during the last quarter. Finally, S. R. Schill & Associates acquired a new position in SPDR S&P Biotech ETF during the first quarter valued at approximately $3,373,000.
SPDR S&P Biotech ETF Stock Performance
Shares of NYSEARCA XBI opened at $108.37 on Thursday. The stock has a market cap of $6.45 billion, a P/E ratio of 11.47 and a beta of 0.97. The firm has a 50 day moving average price of $95.16 and a 200 day moving average price of $86.21. SPDR S&P Biotech ETF has a 52-week low of $66.66 and a 52-week high of $108.62.
SPDR S&P Biotech ETF Profile
SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges.
Featured Articles
- Five stocks we like better than SPDR S&P Biotech ETF
- Stock Average Calculator
- Palantir’s New Healthcare Deal Boosts AI and Data Reach
- Canada Bond Market Holiday: How to Invest and Trade
- GM’s Billion-Dollar Bruise: GM’s Strategic Pivot Makes It a Buy
- Unveiling The Power Of VWAP: A Key Indicator For Traders
- Novo Nordisk’s Akero Therapeutics Buy Targets Eli Lilly’s Lead
Want to see what other hedge funds are holding XBI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for SPDR S&P Biotech ETF (NYSEARCA:XBI – Free Report).
Receive News & Ratings for SPDR S&P Biotech ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for SPDR S&P Biotech ETF and related companies with MarketBeat.com's FREE daily email newsletter.